Merantix

Type

Venture Capital

Status

Active

Location

Berlin, Germany

Total investments

15

Average round size

1M

Portfolio companies

9

Rounds per year

1.88

Lead investments

3

Follow on index

0.40

Areas of investment
AnalyticsB2BFinanceArtificial IntelligenceMachine LearningHealth CareHealth DiagnosticsSaaSManufacturingComputer Vision

Investor highlights

Industry focus
AI/Big DataB2B/EnterpriseHealthcareBiotech/Life SciencesClimate tech Show 2 more
Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 100000000
Fund raised date
2024-02-15

Analytics

Total investments
15
Lead investments
3
Rounds per year
1.88
Follow on index
0.40
Investments by industry
  • Machine Learning (7)
  • Artificial Intelligence (7)
  • Health Care (5)
  • Health Diagnostics (3)
  • Analytics (3)
  • Show 15 more
Investments by region
  • Germany (14)
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
2
Group Appearance index
0.27

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Kausa 01 Aug 2020 Analytics Seed Berlin, Berlin, Germany
OVOM 30 Apr 2024 Artificial Intelligence, Health Care, Predictive Analytics, Fertility Seed 5M Berlin, Berlin, Germany
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.